Literature DB >> 25046175

Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome.

Hany M El-Bassossy1, Nora Dsokey, Ahmed Fahmy.   

Abstract

Vascular dysfunction is an important complication associated with metabolic syndrome (MS). Here we fully characterized vascular complications in a rat model of fructose-induced MS. MS was induced by adding fructose (10%) to drinking water to male Wistar rats of 6 weeks age. Blood pressure (BP) and isolated aorta responses phenylephrine (PE), KCl, acetylcholine (ACh), and sodium nitroprusside (SNP) were recorded after 6, 9, and 12 weeks of fructose administration. In addition, serum levels of glucose, insulin, uric acid, tumor necrosis factor α (TNFα), lipids, advanced glycation end products (AGEs), and arginase activity were determined. Furthermore, aortic reactive oxygen species (ROS) generation, hemeoxygenase-1 expression, and collagen deposition were examined. Fructose administration resulted in a significant hyperinslinemia after 6 weeks which continued for 12 weeks. It was also associated with a significant increase in BP after 6 weeks which was stable for 12 weeks. Aorta isolated from MS animals showed exaggerated contractility to PE and KCl and impaired relaxation to ACh compared with control after 6 weeks which were clearer at 12 weeks of fructose administration. In addition, MS animals showed significant increases in serum levels of lipids, uric acid, AGEs, TNFα, and arginase enzyme activity after 12 weeks of fructose administration. Furthermore, aortae isolated from MS animals were characterized by increased ROS generation and collagen deposition. In conclusion, adding fructose (10%) to drinking water produces a model of MS with vascular complications after 12 weeks that are characterized by insulin resistance, hypertension, disturbed vascular reactivity and structure, hyperuricemia, dyslipidemia, and low-grade inflammation.

Entities:  

Keywords:  Aorta; hypertension; metabolic syndrome; rat; vascular reactivity

Mesh:

Substances:

Year:  2014        PMID: 25046175     DOI: 10.3109/15376516.2014.945109

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  8 in total

Review 1.  Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.

Authors:  Alejandro Gugliucci
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

2.  Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.

Authors:  A Azhar; H M El-Bassossy
Journal:  J Endocrinol Invest       Date:  2014-11-21       Impact factor: 4.256

3.  Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscle.

Authors:  Raffaella Mastrocola; Massimo Collino; Debora Nigro; Fausto Chiazza; Giuseppe D'Antona; Manuela Aragno; Marco A Minetto
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

4.  Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.

Authors:  Hany M El-Bassossy; Malcolm L Watson
Journal:  J Transl Med       Date:  2015-03-06       Impact factor: 5.531

5.  Crocin prevents metabolic syndrome in rats via enhancing PPAR-gamma and AMPK.

Authors:  Mardi M Algandaby
Journal:  Saudi J Biol Sci       Date:  2020-01-27       Impact factor: 4.219

Review 6.  Fructose Intake, Hypertension and Cardiometabolic Risk Factors in Children and Adolescents: From Pathophysiology to Clinical Aspects. A Narrative Review.

Authors:  Marco Giussani; Giulia Lieti; Antonina Orlando; Gianfranco Parati; Simonetta Genovesi
Journal:  Front Med (Lausanne)       Date:  2022-04-12

7.  Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation.

Authors:  Hossam M Abdallah; Hany M El-Bassossy; Gamal A Mohamed; Ali M El-Halawany; Khalid Z Alshali; Zainy M Banjar
Journal:  BMC Complement Altern Med       Date:  2016-09-13       Impact factor: 3.659

8.  Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction.

Authors:  F Chiazza; A S Cento; D Collotta; D Nigro; G Rosa; F Baratta; V Bitonto; J C Cutrin; M Aragno; R Mastrocola; M Collino
Journal:  Biomed Res Int       Date:  2017-10-29       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.